Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subcutaneous Cladribine Plus Pegylated Interpheron Alfa-2a in Advanced Systemic Mastocytosis With D816V and Other Exon 17 KIT Mutations.

NCT01602939 is registered in ClinicalTrials.gov with Hospital Virgen de la Salud as lead sponsor.

NCT NCT01602939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01602939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subcutaneous Cladribine Plus Pegylated Interpheron Alfa-2a in Advanced Systemic Mastocytosis With D816V and Other Exon 17 KIT Mutations.
Lead sponsor
Hospital Virgen de la Salud
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 31, 2012
Completion date
June 30, 2017
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic mastocytosis